Current market catalysts

BTIG Reiterates Buy on Opus Genetics, Maintains $12 Price Target

Zenta Group Inks Agreement To Acquire ZentoAI Intelligent Technology For HK$10M In Cash, $5.844M In Form Class A Shares

If You Invested $1000 In ATI Stock 10 Years Ago, You Would Have This Much Today

ATI (NYSE:ATI) has outperformed the market over the past 10 years by 15.93% on an annualized basis producing an average annual return of 29.51%. Currently, ATI has a market capitalization of $28.09 billion. Buying

Hunter Biden Promised 'Fair Launch' but LAPTOP Meme Coin Crashed 98% in 1 Hour

Hunter Biden’s LAPTOP memecoin crashes 98% within an hour of launch as onchain data reveals insider token distributions before trading began.

Comcast CFO Says Q3 Broadband Subscriber Losses Unlikely To Improve Year-Over-Year, Citing Pressure From Factors Including Rational Fiber Pricing

Leerink Partners Initiates Coverage On Pacira BioSciences with Market Perform Rating, Announces Price Target of $28

Leerink Partners analyst Daniel Clark initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Market Perform rating and announces Price Target of $28.

Leerink Partners Initiates Coverage On Nautilus Biotechnology with Outperform Rating, Announces Price Target of $4

Leerink Partners analyst Puneet Souda initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Outperform rating and announces Price Target of $4.

Revvity shares are trading lower after the company announced it entered into a definitive agreement to acquire Human Cell Design.

Leerink Partners Initiates Coverage On Harrow with Outperform Rating, Announces Price Target of $45

Leerink Partners analyst Daniel Clark initiates coverage on Harrow (NASDAQ:HROW) with a Outperform rating and announces Price Target of $45.

QUICK SPARK: SpaceX Lockup Alert — 319 Million SPCX Shares Unlock Today

SpaceX unlocks 319M insider shares worth up to $47.2 billion on Wednesday. The stock is testing resistance at $150.

Leerink Partners Initiates Coverage On Collegium Pharmaceutical with Outperform Rating, Announces Price Target of $45

Leerink Partners analyst Daniel Clark initiates coverage on Collegium Pharmaceutical (NASDAQ:COLL) with a Outperform rating and announces Price Target of $45.

8-K filing — CME GROUP INC. (CME)

Filed: 2026-09-09 AccNo: 0001193125-26-386091 Size: 170 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

$1000 Invested In Live Nation Entertainment 15 Years Ago Would Be Worth This Much Today

Live Nation Entertainment (NYSE:LYV) has outperformed the market over the past 15 years by 9.0% on an annualized basis producing an average annual return of 22.05%. Currently, Live Nation Entertainment has a market

Can Robinhood's Crypto.com Deal Supercharge Prediction Markets' Growth?

Robinhood Markets has partnered with Crypto.com to route select football event contracts to OG.com's CFTC-regulated exchange, beginning September 8, 2026. The deal comes as prediction markets have become Robinhood's fastest-growing business, generating $156 million in Q2 2026 revenues—surpassing equities and crypto revenues. With football seasons and 2026 midterm elections ahead, the expanded exchange network is expected to enhance liquidity and drive further growth, though regulatory uncertainty and intensifying competition from Interactive Brokers and Coinbase remain headwinds.

Brokers Suggest Investing in SoundHound AI (SOUN): Read This Before Placing a Bet

SoundHound AI (SOUN) has an average brokerage recommendation of 1.75 (Strong Buy/Buy) with five of eight firms rating it Strong Buy. However, the article cautions that brokerage recommendations often have positive bias due to vested interests. The company's Zacks Rank #2 (Buy) rating is based on a 21.8% increase in consensus earnings estimates over the past month, suggesting analyst optimism about near-term price appreciation.

Up to 2 Million Bitcoin Sit Idle Behind a 32% Tax Bill, Sypher Capital Finds

Bitcoin yield strategies have significantly compressed, with basis trades falling below Treasury rates since February 2026 and incentive-driven BTCfi TVL declining 74% from peak. The market is maturing with institutional products like BlackRock's BITA and Goldman Sachs' acquisition of NEOS Investments, shifting focus from highest rates to rates that fit individual holder profiles and tax situations.

2 Dividend Stocks Built to Hold Up When Markets Don't

The article recommends two Dividend Kings—Johnson & Johnson and AbbVie—as defensive dividend stocks that can provide steady income during market volatility. Both companies have demonstrated consistent dividend growth and strong business fundamentals in their pharmaceutical and healthcare portfolios.

Wall Street Analysts Think Lam Research (LRCX) Is a Good Investment: Is It?

Lam Research (LRCX) has an average brokerage recommendation of 1.51 (Strong Buy/Buy) from 34 firms, with 67.7% Strong Buy ratings. However, the article cautions that brokerage recommendations often have positive bias due to institutional vested interests. The company's Zacks Rank #2 (Buy) rating is based on a 0.1% increase in consensus earnings estimates over the past month to $9.33, suggesting modest analyst optimism about near-term price movements.

Wall Street Analysts Think M/I Homes (MHO) Is a Good Investment: Is It?

While Wall Street analysts give M/I Homes an average Buy recommendation (ABR of 2.00), the article cautions that brokerage recommendations often have a positive bias and may not reliably predict stock performance. The Zacks Rank system rates MHO as a Hold (#3), citing unchanged earnings estimates of $12.5 for the current year, suggesting the stock may perform in line with the broader market in the near term.

Full Transcript: Academy Sports Q2 2026 Earnings Call

Academy Sports (NASDAQ:ASO) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our

US Treasury Announces $6B Maximum Par Amount For September 10 Debt Buyback Operation In 10-To-20-Year Sector

https://treasurydirect.gov/instit/annceresult/press/preanre/2026/BBPA_20260910174000.pdf

S&P 500 Up 13% Six Months Into Iran War, and History Says That's Normal

Despite an ongoing military conflict in Iran, the US stock markets remain near all-time highs. History shows that this could often be the case.

Future FinTech Shares Resume Trade

Leerink Partners Initiates Coverage On Bausch & Lomb with Outperform Rating, Announces Price Target of $24

Leerink Partners analyst Daniel Clark initiates coverage on Bausch & Lomb (NYSE:BLCO) with a Outperform rating and announces Price Target of $24.

Ribbon Communications' Technologies To Be Incorporated By In TNS Hosted Cloud Connect Solution

Leerink Partners Initiates Coverage On Amneal Pharmaceuticals with Outperform Rating, Announces Price Target of $23

8-K filing — NEW YORK TIMES CO (NYT)

Filed: 2026-09-09 AccNo: 0001193125-26-386067 Size: 132 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Stifel Maintains Buy on ServiceTitan, Lowers Price Target to $100

CoreWeave And Parallel Works Announce Deployment Of Managed AI, High-Performance Computing Platform For DARPA NODES Program On NVIDIA HGX H100 Systems; Terms Not Disclosed

Stifel Maintains Buy on Revolution Medicines, Raises Price Target to $230